Evidence map›Paper›PMID 28032111›Full record

ArticleJournal of arthropod-borne diseases2016

Epidemiological Study of Endemic Relapsing Fever in Hamadan Province, West of Iran.

Mansour Nazari, Ali Najafi

Abstract read
In one paragraph

Article in Journal of arthropod-borne diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. UnmaskingInternational journal for parasitology. Parasites and wildlife · 2025
    Review
  2. Geographical Features and Seroprevalence ofJournal of arthropod-borne diseases · 2018
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mansour NazariDepartment of Medical Entomology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Ali NajafiDepartment of Medical Entomology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndemic relapsing fever remains under diagnosed in our area according to a low index of suspicion among clinicians, as well as its difficult diagnosis. The goal of this study was to present the epidemiological aspects of the disease in western Iran.

methodsIn this analytical-descriptive cross-sectional study, the epidemiological and clinical aspects of relapsing fever were investigated in Hamadan Province, western Iran from 1999 to 2013. A confirmed patient was defined as a person who had both febrile illness and detected spirochetes by Wright-Giemsa or dark-field microscopy in a peripheral blood smear. For the statistical analysis, the statistical software SPSS was used.

resultsDuring the study period, 276 cases of relapsing fever were recorded that 146 were male. Due to the age group distributions, most of the patients aged less than 20 yr. Patients noticed from April through March, most cases were reported in September (53 cases, 19.2%). Considering time trend of the mentioned disease between 1999 and 2013 showed an increasing trend of disease from 1999 to 2003 (from 2.5% to 21.0%), while the prevalence of disease had a decreasing trend after than from 21.0% in 2003.

conclusionThe rate of endemic relapsing fever is similar in both male and female genders, but its prevalence reduced by increase of age. The trend of the changes in prevalence of the mentioned disease has shown to be downward in recent years probably due to improving health policies especially among children and adolescents and particularly in rural areas.

Indexed as

BorreliaEndemic relapsing feverEpidemiologyIranTick

Identifiers

PMID28032111
PMCPMC5186749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.